Hookipa Pharma Stock Forward View - Price Action Indicator
| HOOK Stock | USD 1.05 0.01 0.94% |
Hookipa Stock outlook is based on your current time horizon. Although Hookipa Pharma's naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Hookipa Pharma's systematic risk associated with finding meaningful patterns of Hookipa Pharma fundamentals over time.
As of now the rsi of Hookipa Pharma's share price is below 20 . This usually indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.66) | EPS Estimate Current Year (2.60) | EPS Estimate Next Year (1.56) | Wall Street Target Price 2 | EPS Estimate Current Quarter (0.64) |
Using Hookipa Pharma hype-based prediction, you can estimate the value of Hookipa Pharma from the perspective of Hookipa Pharma response to recently generated media hype and the effects of current headlines on its competitors.
Hookipa Pharma after-hype prediction price | USD 1.05 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Hookipa Pharma to cross-verify your projections. Hookipa Pharma Additional Predictive Modules
Most predictive techniques to examine Hookipa price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Hookipa using various technical indicators. When you analyze Hookipa charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| 0.04 | 0.015 |
| Check Hookipa Pharma Volatility | Backtest Hookipa Pharma | Information Ratio |
Hookipa Pharma Trading Date Momentum
| On February 08 2026 Hookipa Pharma was traded for 1.05 at the closing time. The top price for the day was 1.05 and the lowest listed price was 1.01 . There was no trading activity during the period 0.0. Lack of trading volume on February 8, 2026 did not cause price change. The trading delta at closing time against the current closing price is 3.81% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Hookipa Pharma to competition |
Other Forecasting Options for Hookipa Pharma
For every potential investor in Hookipa, whether a beginner or expert, Hookipa Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Hookipa Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Hookipa. Basic forecasting techniques help filter out the noise by identifying Hookipa Pharma's price trends.Hookipa Pharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Hookipa Pharma stock to make a market-neutral strategy. Peer analysis of Hookipa Pharma could also be used in its relative valuation, which is a method of valuing Hookipa Pharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Hookipa Pharma Market Strength Events
Market strength indicators help investors to evaluate how Hookipa Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Hookipa Pharma shares will generate the highest return on investment. By undertsting and applying Hookipa Pharma stock market strength indicators, traders can identify Hookipa Pharma entry and exit signals to maximize returns.
Hookipa Pharma Risk Indicators
The analysis of Hookipa Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Hookipa Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting hookipa stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.23 | |||
| Semi Deviation | 1.1 | |||
| Standard Deviation | 1.73 | |||
| Variance | 2.98 | |||
| Downside Variance | 3.85 | |||
| Semi Variance | 1.21 | |||
| Expected Short fall | (1.97) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Hookipa Pharma
The number of cover stories for Hookipa Pharma depends on current market conditions and Hookipa Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Hookipa Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Hookipa Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Hookipa Pharma Short Properties
Hookipa Pharma's future price predictability will typically decrease when Hookipa Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Hookipa Pharma often depends not only on the future outlook of the potential Hookipa Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Hookipa Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 12.5 M | |
| Cash And Short Term Investments | 39.7 M |
Check out Historical Fundamental Analysis of Hookipa Pharma to cross-verify your projections. For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hookipa Pharma. Market participants price Hookipa higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Hookipa Pharma assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (4.83) | Revenue Per Share | Quarterly Revenue Growth (0.94) | Return On Assets | Return On Equity |
Investors evaluate Hookipa Pharma using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Hookipa Pharma's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Hookipa Pharma's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Hookipa Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hookipa Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Hookipa Pharma's market price signifies the transaction level at which participants voluntarily complete trades.